Phathom Pharmaceuticals (NASDAQ:PHAT) Receives Buy Rating from Needham & Company LLC wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Needham & Company LLC reiterated their buy rating on shares of Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) in a research note released on Friday, Benzinga reports. They currently have a $26.00 price target on the stock. Phathom Pharmaceuticals Stock Up 1.9 % PHAT stock opened at $9.35 on Friday. The stock has a market capitalization […]
Phathom Pharmaceuticals (NASDAQ:PHAT – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at Needham & Company LLC in a note issued to investors on Friday, Benzinga reports. They presently have a $26.00 price target on the stock. Needham & Company LLC’s price objective suggests a potential upside of 188.89% from the […]
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report) insider Terrie Curran sold 16,851 shares of the firm’s stock in a transaction that occurred on Friday, March 22nd. The stock was sold at an average price of $9.11, for a total transaction of $153,512.61. Following the sale, the insider now directly owns 410,784 shares of the […]
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report) shot up 9.4% during trading on Tuesday . The company traded as high as $10.65 and last traded at $10.16. 351,678 shares traded hands during mid-day trading, a decline of 54% from the average session volume of 761,808 shares. The stock had previously closed at $9.29. Analyst […]